 |
|
|
| |
Final Results PROVIDE Study: Boceprevir in null-responders
|
| |
| |
Reported by Jules Levin
DDW 2013 May 18-21 Orlando Florida
J Vierling1, FA Helmond2, J Wahl2, W Deng2, JP Bronowicki3
1Baylor College of Medicine, Houston, TX, USA, 2Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA; 3University Henri Poincare of Nancy, Vandoeuvre-les-Nancy, France.
|
| |
|
|
|
|
|
